HomeCompareSMPNY vs JNJ

SMPNY vs JNJ: Dividend Comparison 2026

SMPNY yields 2.51% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SMPNY wins by $143.1K in total portfolio value
10 years
SMPNY
SMPNY
● Live price
2.51%
Share price
$19.96
Annual div
$0.50
5Y div CAGR
51.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$173.3K
Annual income
$76,782.62
Full SMPNY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — SMPNY vs JNJ

📍 SMPNY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSMPNYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SMPNY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SMPNY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SMPNY
Annual income on $10K today (after 15% tax)
$212.93/yr
After 10yr DRIP, annual income (after tax)
$65,265.23/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, SMPNY beats the other by $61,279.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SMPNY + JNJ for your $10,000?

SMPNY: 50%JNJ: 50%
100% JNJ50/50100% SMPNY
Portfolio after 10yr
$101.8K
Annual income
$40,736.01/yr
Blended yield
40.01%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SMPNY
No analyst data
Altman Z
1.6
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SMPNY buys
0
JNJ buys
0
No recent congressional trades found for SMPNY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSMPNYJNJ
Forward yield2.51%2.13%
Annual dividend / share$0.50$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR51.2%28%
Portfolio after 10y$173.3K$30.3K
Annual income after 10y$76,782.62$4,689.40
Total dividends collected$142.9K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SMPNY vs JNJ ($10,000, DRIP)

YearSMPNY PortfolioSMPNY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,079$378.76$10,592$272.30+$487.00SMPNY
2$12,447$592.95$11,289$357.73+$1.2KSMPNY
3$14,260$941.39$12,123$472.89+$2.1KSMPNY
4$16,782$1,523.99$13,141$629.86+$3.6KSMPNY
5$20,491$2,534.43$14,408$846.81+$6.1KSMPNY
6$26,299$4,372.91$16,021$1,151.60+$10.3KSMPNY
7$36,070$7,930.52$18,122$1,588.22+$17.9KSMPNY
8$53,965$15,370.34$20,930$2,228.20+$33.0KSMPNY
9$90,238$32,495.22$24,792$3,191.91+$65.4KSMPNY
10$173,337$76,782.62$30,274$4,689.40+$143.1KSMPNY

SMPNY vs JNJ: Complete Analysis 2026

SMPNYStock

Sompo Holdings, Inc. provides property and casualty (P&C) insurance services in Japan and internationally. The company operates through Domestic P&C Insurance Business, Overseas Insurance Business, Domestic Life Insurance Business, and Nursing Care and Healthcare Business segments. It offers various P&C insurance products, including automobile, fire, personal accident, and marine, as well as security, risk management, assistance, and warranty services; and life insurance products. The company also provides nursing care and healthcare services; and customer security, health, and wellbeing support services. In addition, it offers asset management services; home remodeling services; health support services comprising health guidance and health counseling, and employee assistance programs; and wellness communication services. The company was formerly known as Sompo Japan Nipponkoa Holdings, Inc. and changed its name to Sompo Holdings, Inc. in October 2016. The company was incorporated in 2010 and is headquartered in Tokyo, Japan.

Full SMPNY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SMPNY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SMPNY vs SCHDSMPNY vs JEPISMPNY vs OSMPNY vs KOSMPNY vs MAINSMPNY vs ABBVSMPNY vs MRKSMPNY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.